Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97].
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Center for Child and Family Policy, Duke University, Durham, NC, USA. Electronic address: Litzy.wu@duke.edu.
Li-Tzy
LT
Wu
Department of Population Health, New York University School of Medicine, New York, NY, USA.
Jennifer
J
McNeely
National Institute on Drug Abuse, Bethesda, MD, USA.
Geetha A
GA
Subramaniam
The EMMES Corporation, Rockville, MD, USA.
Gaurav
G
Sharma
The EMMES Corporation, Rockville, MD, USA.
Paul
P
VanVeldhuisen
Friends Research Institute, Inc., Baltimore, MD, USA.
Robert P
RP
Schwartz